Ceva producing aMPV experimental autogenous vaccine using US-origin isolate
Ceva Animal Health has started antigen production for an experimental autogenous vaccine to fight the emerging avian metapneumovirus (aMPV) disease.
Ceva Animal Health has started antigen production for an experimental autogenous vaccine to fight the emerging avian metapneumovirus (aMPV) disease.
Ancera has released two new microbial-detection tools designed to identify and enumerate Clostridium perfringens and total viable bacteria (TVB) in poultry.
ImagoAI Inc. — a company based in Milpitas, California, specializing in hyperspectral imaging and AI technology — says it is collaborating with USDA to develop a hand-held device called GalaxyLyte, which makes mycotoxin testing accessible anywhere.
Modern Poultry, a news website focused on live production, is celebrating “day 365” serving the global poultry industry.
Looking to up your game with litter management? Visit Litterpedia, a new resource developed by AgriFutures in Australia.
Ancera has released a new suite of comprehensive monitoring tools to provide allied companies of the poultry industry with real-time, third-party evidence demonstrating product efficacy.
Merck Animal Health has entered into an agreement with Cambridge Technologies, an independent custom vaccine company based in Worthington, Minnesota, to sell and market its innovative autogenous poultry vaccines in the US.
USDA’s Center for Veterinary Biologics has granted Huvepharma a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine.
Merck Animal Health has introduced FLOCKSECURE™ poultry health portal, an innovative web-based platform solution designed to capture, maintain, distribute and analyze data from post-mortem sessions.
A recent study comparing traditional lighting with gradient lighting demonstrated significant benefits to poultry flocks, including improved feed conversion ratio (FCR), enhanced welfare indicators and reduced stress levels.
Merck Animal Health has introduced Innovax®-ILT-IBD, a vaccine that provides combined protection and immunization against Marek’s disease (MD), infectious laryngotracheitis (ILT) and infectious bursal disease (IBD) in a single injection.
Cargill has introduced REVEAL™ Layers, a non-invasive near-infrared (NIR) technology that helps producers and nutritionists make real-time decisions regarding hens’ diets to support their flocks’ long-term production and performance.
Copyright ©Feeks Media LLC, 2024 | All rights reserved
info@modernpoultry.media
privacy policy | site map